From: Prediction of resistance to chemotherapy in ovarian cancer: a systematic review
Gene symbol | Number of studies | Function | Expression links to cancer in literature |
---|---|---|---|
AGR2 | 4 | Cell migration and growth | Prostate, breast, ovarian, pancreatic |
MUTYH | 3 | Oxidative DNA damage repair | Colorectal |
AKAP12 | 3 | Subcellular compartmentation of PKA | Colorectal, lung, prostate |
TP53 | 3 | Cell cycle regulation | Breast |
TOP2A | 3 | Required for DNA replication | Breast, prostate, ovarian |
FOXA2 | 3 | Liver-specific transcription factor | Lung, prostate |
SRC | 2 | Regulation of cell growth | Colon, liver, lung, breast, pancreatic |
SIVA1 | 2 | Pro-apoptotic protein | Many cancers |
ALDH9A1 | 2 | Aldehyde dehydrogenase | Many cancers |
LGR5 | 2 | Associated with stem cells | Cancer stem cells |
EHF | 2 | Epithelial differentiation and proliferation | Prostate |
BAX | 2 | Apoptotic activator | Colon, breast, prostate, gastric, leukaemia |
CES2 | 2 | Intestine drug clearance | Colorectal |
CPE | 2 | Synthesis of hormones and neurotransmitters | Â |
FGFBP1 | 2 | Cell proliferation, differentiation and migration | Colorectal, pancreatic |
TUBB4A | 2 | Component of microtubules | Â |
ZNF12 | 2 | Transcription regulation | Â |
RBM39 | 2 | Steroid hormone receptor-mediated transcription | Â |
RFC3 | 2 | Required for DNA replication | Â |
GNPDA1 | 2 | Triggers calcium oscillations in mammalian eggs | Â |
ANXA3 | 2 | Regulation of cellular growth | Prostate, ovarian |
NFIB | 2 | Activates transcription and replication | Breast |
ACTR3B | 2 | Actin cyctoskeleton organisation | Lung |
YWHAE | 2 | Mediates signal transduction | Lung, endometrial |
CYP51A1 | 2 | Drug metabolism and lipid synthesis | Â |
HMGCS1 | 2 | Cholesterol synthesis and ketogenesis | Â |
ZMYND11 | 2 | Transcriptional repressor | Â |
FADS2 | 2 | Regulates unsaturation of fatty acids | Â |
SNX7 | 2 | Family involved in intracellular trafficking | Â |
ARHGDIA | 2 | Regulates the GDP/GTP exchange reaction of the Rho proteins | Prostate, lung, |
NDST1 | 2 | Inflammatory response | Prostate, breast |
AOC1 | 2 | Catalyses degredation of such as histamine and spermidine | Â |
DAP | 2 | Positive mediator of programmed cell death | Â |
ERCC8 | 2 | Transcription-coupled nucleotide excision repair | Â |
GUCY1B3 | 2 | Catalyzes conversion of GTP to the second messenger cGMP | Â |
HDAC1 | 2 | Control of cell proliferation and differentiation | Prostate, breast, colorectal, gastric |
HDAC2 | 2 | Transcriptional regulation and cell cycle progression | Cervical, gastric, colorectal |
IGFBP5 | 2 | Cell proliferation, differentiation, survival, and motility | Breast |
IL6 | 2 | Transcriptional inflammatory response, B cell maturation | Many cancers |
LSAMP | 2 | Neuronal surface glycoprotein | Osteosarcoma |
MDK | 2 | Cell growth, migration, angiogenesis | Many cancers |
MYCBP | 2 | Stimulates the activation of E box-dependent transcription | Â |
S100A10 | 2 | Transport of neurotransmitters | Colorectal, lung, breast |
SLC1A3 | 2 | Glutamate transporter | Â |
NCOA1 | 2 | Stimulates hormone-dependent transcription | Breast, prostate |
TIAM1 | 2 | Modulates the activity of Rho GTP-binding proteins | Many cancers |
VEGFA | 2 | Angiogenesis, cell growth, cell migration, apoptosis | Many cancers |
RPL36 | 2 | Component of ribosomal 60S subunit | Â |
LBR | 2 | Anchors lamina and heterochromatin to the nuclear membrane | Â |
ABCB1 | 2 | ATP-dependent drug efflux pump for xenobiotic compounds | Many cancers |
FASLG | 2 | Required for triggering apoptosis in some cell types | Many cancers |
TIMP1 | 2 | Extracellular matrix, proliferation, apoptosis | Many cancers |
FN1 | 2 | Cell adhesion, motility, migration processes | Many cancers |
TGFB1 | 2 | Proliferation, differentiation, adhesion, migration | Prostate, breast, colon, lung, bladder |
XPA | 2 | DNA excision repair | Many cancers |
ABCB10 | 2 | Mitochondrial ATP-binding cassette transporter | Â |
POLH | 2 | Polymerase capable of replicating UV-damaged DNA for repair | Â |
ITGAE | 2 | Adhesion, intestinal intraepithelial lymphocyte activation | Â |
ZNF200 | 2 | Zinc finger protein | Â |
COL3A1 | 2 | Collagen type III, occurring in most soft connective tissues | Â |
ACKR3 | 2 | G-protein coupled receptor | Â |
EPHB3 | 2 | Mediates developmental processes | Lung, colorectal |
NBN | 2 | Double-strand DNA repair, cell cycle control | Â |
PCF11 | 2 | May be involved in Pol II release following polymerisation | Â |
DFNB31 | 2 | Sterocilia elongation, actin cystoskeletal assembly | Â |
BRCA2 | 2 | Double-strand DNA repair | Breast, ovarian |
AADAC | 2 | Arylacetamide deacetylase | Â |
CD38 | 2 | Glucose-induced insulin secretion | Leukaemia |
CHIT1 | 2 | Involved in degradation of chitin-containing pathogens | Â |
CXCR4 | 2 | Receptor specific for stromal-derived-factor-1 | Breast, glioma, kidney, prostate |
EFNB2 | 2 | Mediates developmental processes | Â |
MECOM | 2 | Apoptosis, development, cell differentiation, proliferation | Leukaemia |
FILIP1 | 2 | Controls neocortical cell migration | Ovarian |
HSPB7 | 2 | Heat shock protein | Â |
LRIG1 | 2 | Regulator of signaling by receptor tyrosine kinases | Glioma |
MMP1 | 2 | Breakdown of extracellular matrix | Gastric, breast |
PSAT1 | 2 | Phosphoserine aminotransferase | Â |
SDF2L1 | 2 | Part of endoplasmic reticulum chaperone complex | Â |
TCF15 | 2 | Regulation of patterning of the mesoderm | Â |
EPHB2 | 2 | Contact-dependent bidirectional signaling between cells | Colorectal |
ETS1 | 2 | Involved in stem cell development, cell senescence and death | Many cancers |
TRIM27 | 2 | Male germ cell differentiation | Ovarian, endometrial, prostate |
MARK4 | 2 | Mitosis, cell cycle control | Glioma |
B4GALT5 | 2 | Biosynthesis of glycoconjugates and saccharides | Â |